EP0828461A1 - Articulated stent - Google Patents

Articulated stent

Info

Publication number
EP0828461A1
EP0828461A1 EP95918298A EP95918298A EP0828461A1 EP 0828461 A1 EP0828461 A1 EP 0828461A1 EP 95918298 A EP95918298 A EP 95918298A EP 95918298 A EP95918298 A EP 95918298A EP 0828461 A1 EP0828461 A1 EP 0828461A1
Authority
EP
European Patent Office
Prior art keywords
stent
plurality
links
articulated
flexible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP95918298A
Other languages
German (de)
French (fr)
Other versions
EP0828461B1 (en
EP0828461B2 (en
EP0828461A4 (en
Inventor
Gregory Pinchasik
Jacob Richter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medinol Ltd
Original Assignee
Medinol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Application filed by Medinol Ltd filed Critical Medinol Ltd
Priority claimed from EP06005709A external-priority patent/EP1669043A3/en
Priority to PCT/US1995/005095 priority Critical patent/WO1996033671A1/en
Publication of EP0828461A1 publication Critical patent/EP0828461A1/en
Publication of EP0828461A4 publication Critical patent/EP0828461A4/en
Publication of EP0828461B1 publication Critical patent/EP0828461B1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27170503&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP0828461(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of EP0828461B2 publication Critical patent/EP0828461B2/en
Application granted granted Critical
Anticipated expiration legal-status Critical
Application status is Expired - Lifetime legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/061Blood vessels provided with means for allowing access to secondary lumens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/828Means for connecting a plurality of stents allowing flexibility of the whole structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • A61F2002/91541Adjacent bands are arranged out of phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0029Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in bending or flexure capacity

Abstract

A connector (110) for connecting adjacent areas of adjacent segments (102) of an articulated stent, the connector includes a plurality of flexible links (112), wherein each of the flexible links includes a plurality of portions with each pair of neighboring portions having an area of inflection therebetween and wherein during expansion of said stent, said area of inflection of each flexible link remains inflected.

Description

APPLICATION FOR PATENT

Title: ARTICULATED STENT

FIELD AND BACKGROUND OF THE INVENTION

The present invention relates to stents which are implanted as part

of a balloon angioplasty procedure within a bodily conduit of a living

animal or a human to maintain patency. In particular, the present invention

relates to articulated intravascular stents for delivery through or

implantation in a blood vessel having a curved portion.

Intravascular stents having a constricted diameter for delivery

through a blood vessel and an expanded diameter for applying a radially

outwardly extending force for supporting the blood vessel are known in the

art. Articulated intravascular stents for either delivery through a curved

blood vessel or implanted therein are also known in the art.

Self-expandable articulated stents are described, for example, in U.S .

Patent No. 5,104,404 entitled "Articulated Stent" to Wolff. Balloon

expandable articulated stents are commercially available under the trade

name Palmaz-Schatz Balloon-Expandable Stents from Johnson & Johnson

Intervention Systems Co.

A prior art self-expandable articulated intravascular stent 10

deployed in a curved blood vessel 16 is now described with reference to

Figure 1 which is, in actual fact, Figure 2 of the above referenced U.S.

Patent No. 5, 104,404. Stent 10 is made up of a number of individual segments 12 articulated by hinges 14 connected at each end to segments

12. Stent 10 is preferably fabricated from memory shape material, for

example, nitinol, and as such is self expandable after delivery from a

delivery system described in U.S Patent No. 4,830,003 to Wolff et al.

However, these prior art articulated intravascular stents suffer from a

number of disadvantages both during delivery through a curved blood

vessel and when implanted therein as will now described.

The delivery of stent 10 through curved blood vessel 16 is more

complicated than the delivery of a non-articulated stent in that stent 10 has

to be angularly oriented such that its hinges 14 are located towards the

convex portion of blood vessel 16 so that stent 10 can be flexed inward.

In the present example, it will be noted that hinges 14 are located on the

same side of segments 12 because blood vessel 16 has only a simple curve

in one plane. It can be readily appreciated that delivery of stents through

blood vessels which have one or more curved portions which are not in the

same plane is even more complicated and generally requires specially

constructed stents.

Even when implanted in a curved blood vessel 16, stents 10 are

shown to be lacking in that the gaps between segments 12 render the

curved portion of blood vessel 16 without support. Furthermore, the gaps

at the convex portion of blood vessel 16 are substantially greater than the 96/33671 PCI7US95/05095

3 gaps at the concave portion thereof, thereby inducing non-uniform and

therefore undesirable stresses on blood vessel 16.

Therefore, it would be highly desirable to have an articulated stent

which does not require any particular angular orientation when being

delivered through a curved bodily conduit and provides continuous and

uniform support for both straight and curved portions of a bodily conduit

when implanted.

It would also be highly desirable the structure of a stent does not

depend on the particular orientations of curved portions of a blood vessel.

SUMMARY OF THE INVENTION

The object of the present invention is for an articulated stent which

can be delivered through a curved bodily conduit using a routine medical

procedure and a conventional stent delivery system. Furthermore, the stent

provides continuous and uniform support for both straight and curved

portions of a bodily conduit when implanted. Still further, the structure of

a stent and its support of a bodily conduit do not depend on the

orientations of the curved portions of the conduit.

The objective of the present invention is achieved by an articulated

stent, comprising: (a) at least two substantially rigid segments; and (b) a

flexible connector for connecting adjacent segments, wherein the connector assumes a substantially cylindrical configuration when relaxed and a

differentially stretched and compressed curved configuration when flexed.

After expansion, the rigid segments of the stent preferably present

a fine diamond shaped mesh having 1 mm long sides to provide continuous

and uniform support for straight portions of a bodily conduit.

The connectors can be implemented as a plurality of substantially

helical links connecting adjacent segments. Alternatively, the connectors

can be implemented as links each having at least one kink. The connectors

typically have between 8-24 links to provide continuous and uniform

support for both straight and curved portions of a bodily conduit.

The stents have constricted diameters for intraluminal delivery and

are then deformed, by the inflation of a balloon forming part of their

catheter delivery system, to expanded diameters for applying radially

outwardly extending forces for supporting the lumen of bodily conduits.

The constricted and expanded diameters of the stents typically fall in the

ranges of 1.0-3.5 mm and 3.5-10.0 mm, respectively.

The stents are preferably fabricated from low memory, more plastic

than elastic, bio-compatible materials, for example, stainless steel 316L,

gold, tantalum, etc. which enables them to be plastically deformed from

their constricted diameters to their expanded diameters.

A typical stent for implantation in a human coronary artery is 9-21

mm long comprising three to seven 2.2 mm long stent segments connected by two to six 1 mm long connectors such that the ends of the stent subtend

between a 45° to 135° angle at a radius of curvature of approximately 9

mm when flexed.

BRIEF DESCRIPTION OF THE DRAWINGS

The invention is herein described, by way of example only, with

reference to the accompanying drawings, wherein:

FIG. 1 shows a close-up view of a prior art articulated stent of

deployed in a curved blood vessel;

FIGS. 2a and 2b show a preferred embodiment of an articulated

stent, constructed and operative according to the teachings of the present

invention, in its relaxed and flexed states before plastic deformation;

FIG. 2c shows the expanded stent of Figure 2 after plastic

deformation;

FIG. 2d shows the stent of Figure 2 mounted on a catheter in its

flexed state;

FIGS. 2e and 2f show the stent of Figure 2 before and after

expansion by a balloon forming part of its catheter delivery system;

FIGS. 3a and 3b show a second embodiment of an articulated stent,

constructed and operative according to the teachings of the present

invention, in its relaxed and flexed states before plastic deformation; and FIG. 3c shows the expanded stent of Figure 3 after plastic

deformation.

DESCRIPTION OF THE PREFERRED EMBODIMENTS

The present invention is of an articulated stent for delivering through

a curved bodily conduit, for example, a peripheral or coronary artery of a

living animal or a human and implantation therein as part of a balloon

angioplasty procedure to maintain patency.

The principles and operation of the articulated stent of the present

invention may be better understood with reference to the drawings and the

accompanying description.

Referring now to the drawings, Figures 2a-2c show an articulated

stent, generally designated 100, constructed and operative according to the

teachings of the present invention, generally comprising a number of

substantially rigid segments 102 connected by connectors 110.

Segments 102 are preferably made up to present a fine diamond

mesh of interconnected diamond shaped cells 108 having 1 mm sides on

expansion as best seen in Figure 2c. Depending on the intended diameter

of stent 100, segments 102 typically comprise between 8-24 diamond

shaped cells 108.

Connectors 110 comprise links 112 connecting a front end 104 to

a tail end 106 of adjacent segments 102. Links 112 preferably extend in a substantially helical fashion between apexes of diamond shaped cells 108

at front and rear ends 104 and 106 of adjacent segments 102 such that the

number of links 112 equals the number of cells 108. Links 112 are

preferably evenly deployed around perimeters of segments 102 such that

connectors 110 can be equally flexed in any direction and to provide

continuous and uniform support to both straight and curved portions of a

bodily conduit.

Alternate connectors 110 at front and rear ends 104 and 106,

respectively, of a segment 102 preferably have links 112 wound in

clockwise and counter clockwise directions. Alternately winding

connectors 110 ensures that the rotational displacement of links 112 and

adjacent segments 102 relative to the walls of a blood vessel and more

importantly the balloon of its delivery system is minimized when stent 100

is expanded.

It is particular feature of the present invention that connectors 110

have a generally cylindrical configuration when stent 100 is relaxed as best

seen in Figure 2a and a differentially stretched and compressed curved

configuration when stent 100 is flexed as best seen in Figure 2b. The

flexed configuration is brought about by two relatively opposing

displacements of links 112. First, the differential stretching of connectors

110 occurs at the convex portion thereof denoted 114 by links 112 being

displaced away from one another. Second, the differential compressing of connectors 110 occurs at the concave portion thereof denoted 116 by links

112 being displaced towards one another.

Stent 100 has a constricted diameter for delivery through a curved

bodily conduit as shown in Figures 2a and 2b and an expanded diameter

as shown in Figure 2c for supporting a bodily conduit. Stent 100 is

preferably fabricated from low memory, more plastic than elastic, bio-

compatible material, for example, stainless steel 316L, gold, tantalum, etc.

which enables it to be plastically deformed from its constricted diameter

to its expanded diameter. The constricted and expanded diameters of stent

100 typically fall in the ranges of 1.0-3.5 mm and 3.5-10.0 mm,

respectively.

With reference now to Figures 2d-2f, stent 100 is shown overlying

a balloon 118 forming part of its catheter delivery system 120. Stent 100

is mounted on its catheter delivery system 120 in its constricted diameter

state shown in Figure 2e for plastic deformation through inflation of

balloon 118 to its expanded diameter shown in Figure 2f for supporting the

walls of a bodily conduit. An exemplary stent for implantation in a human

coronary artery, is typically 15 mm long made up of five 2.2 mm long

segments 102 connected by four 1 mm long connectors 110 and capable

of flexion such that its ends subtend a 90° angle at a radius of curvature

of approximately 9 mm. The delivery of articulated stent 100 is considerably simpler than the

delivery of prior art articulated stent 10 because stent 100 is equally

flexible in all direction and therefore does not require a dedicated angular

orientation to pass a particular curved portion. This advantage is

particularly important for delivery through blood vessels having multiple

curved portions. It is a further advantage of stent 100 over prior art stents

10, that stent 100 provides continuous and uniform support along the entire

length of a blood vessel by means of segments 102 and unflexed

connectors 110 supporting straight portions thereof while connector

portions 114 and 116 supporting convex and concave curved portions

thereof, respectively.

With reference now to Figures 3a and 3b, an articulated stent 122

is shown in which connectors 124 comprise links 126 having one or more

kinks 128. The design of connectors 124 is preferred to that of connector

110 because stent 100 may have a tendency to rupture balloon 118 due to

two reasons. First, links 112 overlying the convex portion of balloon 118

have a tendency to be biased inward when stent 100 is flexed. Second,

segments 102 display a rotational displacement relative to balloon 118

when stent 100 is expanded.

In this case, the differentially stretched and compressed curved

configuration of connector 124 is brought about by two relatively opposing

displacements of links 112 as before except that the differential stretching of connectors 124 at convex portion 114 occurs by kinks 128 being

somewhat straightened out while the differential compressing of connectors

124 at concave portion 116 occurs by kinks 128 being more acutely bent.

In a similar fashion to stent 100, stent 122 has a constricted diameter

for delivery through a curved bodily conduit as shown in Figures 3a and

3b and an expanded diameter as shown in Figure 3c for supporting a

bodily conduit when implanted therein.

While the invention has been described with respect to a limited

number of embodiments, it will be appreciated that many variations,

modifications and other applications of the invention may be made.

Claims

1. A connector for connecting adjacent areas of adjacent segments of an articulated stent, the connector comprising: a plurality of flexible links, wherein each of said flexible links includes a plurality of portions with each pair of neighboring portions having an area of inflection therebetween.
2. A connector according to claim 1 and wherein, during expansion of said stent, said area of inflection of each flexible link remains inflected.
3. An articulated stent, comprising:
(a) at least two substantially rigid segments having a plurality of connected cells each having apices, wherein, upon expansion, each of said rigid segments presents a substantially cylindrical diamond mesh; and
(b) a flexible connector, comprising a plurality of flexible links wherein each of said flexible links connects apices of adjacent cells on adjacent rigid segments; each of said flexible links includes a plurality of portions with each pair of neighboring portions having an area of inflection therebetween, and during expansion of said stent, said area of inflection remains inflected.
4. The stent as in claim 3, wherein said plurality of links includes between 8-24 links.
5. The stent as in claim 3 made from bio-compatible material capable of a more plastic than elastic deformation.
6. The stent as in claim 5, wherein said material is stainless steel.
7. The stent as in claim 5, wherein said material is gold.
8. The stent as in claim S, wherein said material is tantalum
EP95918298A 1995-04-26 1995-04-26 articulated stent with links having kinks Expired - Lifetime EP0828461B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/US1995/005095 WO1996033671A1 (en) 1995-04-26 1995-04-26 Articulated stent

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01106391A EP1110515B1 (en) 1995-04-26 1995-04-26 Articulated stent
EP06005709A EP1669043A3 (en) 1995-04-26 1995-04-26 Articulated stent
HK01108322A HK1038175A1 (en) 1995-04-26 2001-11-26 Articulated stent

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP01106391A Division EP1110515B1 (en) 1995-04-26 1995-04-26 Articulated stent

Publications (4)

Publication Number Publication Date
EP0828461A1 true EP0828461A1 (en) 1998-03-18
EP0828461A4 EP0828461A4 (en) 1999-09-15
EP0828461B1 EP0828461B1 (en) 2003-02-19
EP0828461B2 EP0828461B2 (en) 2006-07-05

Family

ID=27170503

Family Applications (2)

Application Number Title Priority Date Filing Date
EP01106391A Revoked EP1110515B1 (en) 1995-04-26 1995-04-26 Articulated stent
EP95918298A Expired - Lifetime EP0828461B2 (en) 1995-04-26 1995-04-26 articulated stent with links having kinks

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP01106391A Revoked EP1110515B1 (en) 1995-04-26 1995-04-26 Articulated stent

Country Status (23)

Country Link
EP (2) EP1110515B1 (en)
JP (1) JPH11501551A (en)
AT (2) AT232703T (en)
AU (1) AU711431B2 (en)
BR (1) BR9510585A (en)
CA (1) CA2219488C (en)
CZ (1) CZ292021B6 (en)
DE (4) DE69529692T3 (en)
DK (1) DK0828461T3 (en)
EE (1) EE03800B1 (en)
ES (1) ES2190453T3 (en)
FI (1) FI974063A (en)
HK (1) HK1038175A1 (en)
LV (1) LV12035B (en)
NO (1) NO310333B1 (en)
NZ (1) NZ285241A (en)
PL (1) PL179854B1 (en)
PT (1) PT828461E (en)
RO (1) RO115496B1 (en)
RU (1) RU2154443C2 (en)
SI (1) SI0828461T1 (en)
SK (1) SK145797A3 (en)
WO (1) WO1996033671A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7279004B2 (en) 1998-03-30 2007-10-09 Innovational Holdings, Llc. Expandable medical device with curved hinge

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733303A (en) * 1994-03-17 1998-03-31 Medinol Ltd. Flexible expandable stent
US6461381B2 (en) 1994-03-17 2002-10-08 Medinol, Ltd. Flexible expandable stent
EP0971644A1 (en) * 1997-03-25 2000-01-19 G. David Jang Intravascular stent
US5906759A (en) 1996-12-26 1999-05-25 Medinol Ltd. Stent forming apparatus with stent deforming blades
US7959664B2 (en) 1996-12-26 2011-06-14 Medinol, Ltd. Flat process of drug coating for stents
US8828077B2 (en) 2006-03-15 2014-09-09 Medinol Ltd. Flat process of preparing drug eluting stents
US5827321A (en) 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
US6071308A (en) 1997-10-01 2000-06-06 Boston Scientific Corporation Flexible metal wire stent
DE19753123B4 (en) * 1997-11-29 2006-11-09 B. Braun Melsungen Ag stent
US8382821B2 (en) 1998-12-03 2013-02-26 Medinol Ltd. Helical hybrid stent
US9155639B2 (en) 2009-04-22 2015-10-13 Medinol Ltd. Helical hybrid stent
US9039755B2 (en) 2003-06-27 2015-05-26 Medinol Ltd. Helical hybrid stent
FR2793673B1 (en) 1999-05-18 2001-10-12 Jean Marie Lefebvre Endoprosthesis type tubular stent has low crush strength
US8920487B1 (en) 2000-03-01 2014-12-30 Medinol Ltd. Longitudinally flexible stent
US7758627B2 (en) 2000-03-01 2010-07-20 Medinol, Ltd. Longitudinally flexible stent
US7621947B2 (en) 2000-03-01 2009-11-24 Medinol, Ltd. Longitudinally flexible stent
SG86458A1 (en) 2000-03-01 2002-02-19 Medinol Ltd Longitudinally flexible stent
US8202312B2 (en) 2000-03-01 2012-06-19 Medinol Ltd. Longitudinally flexible stent
US6723119B2 (en) 2000-03-01 2004-04-20 Medinol Ltd. Longitudinally flexible stent
US8496699B2 (en) 2000-03-01 2013-07-30 Medinol Ltd. Longitudinally flexible stent
US7828835B2 (en) 2000-03-01 2010-11-09 Medinol Ltd. Longitudinally flexible stent
US7141062B1 (en) 2000-03-01 2006-11-28 Medinol, Ltd. Longitudinally flexible stent
US20020072792A1 (en) * 2000-09-22 2002-06-13 Robert Burgermeister Stent with optimal strength and radiopacity characteristics
US6796999B2 (en) 2001-09-06 2004-09-28 Medinol Ltd. Self articulating stent
DE10243136A1 (en) * 2002-09-17 2004-05-19 Campus Medizin & Technik Gmbh Stent for implantation in or around a hollow organ
US7846198B2 (en) 2002-12-24 2010-12-07 Novostent Corporation Vascular prosthesis and methods of use
US20050165469A1 (en) 2002-12-24 2005-07-28 Michael Hogendijk Vascular prosthesis including torsional stabilizer and methods of use
US7763064B2 (en) 2004-06-08 2010-07-27 Medinol, Ltd. Stent having struts with reverse direction curvature
AU2012201649B2 (en) * 2005-04-04 2013-10-24 Flexible Stenting Solutions, Inc. Flexible stent
CN102309370B (en) * 2005-04-04 2015-04-15 灵活支架解决方案股份有限公司 Flexible stent
US7537608B2 (en) * 2006-05-23 2009-05-26 Boston Scientific Scimed, Inc. Stent with variable crimping diameter
US8720728B2 (en) 2007-03-09 2014-05-13 Simplehuman, Llc Trash can
US7988723B2 (en) * 2007-08-02 2011-08-02 Flexible Stenting Solutions, Inc. Flexible stent
US9579103B2 (en) 2009-05-01 2017-02-28 Endologix, Inc. Percutaneous method and device to treat dissections
US20110009941A1 (en) * 2009-07-08 2011-01-13 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
ES2549000T3 (en) 2009-07-27 2015-10-22 Endologix, Inc. endoprosthesis
ES2541465T3 (en) * 2009-09-16 2015-07-20 Bentley Innomed Gmbh Stent expansible elements
US9434538B2 (en) 2010-03-12 2016-09-06 Simplehuman, Llc Trash can
WO2012068298A1 (en) 2010-11-17 2012-05-24 Endologix, Inc. Devices and methods to treat vascular dissections
CA2808725A1 (en) 2012-03-09 2013-09-09 Simplehuman, Llc Trash cans with features to aid in actuation
US9790025B2 (en) 2012-03-09 2017-10-17 Simplehuman, Llc Trash can with clutch mechanism
US8872459B2 (en) 2012-03-09 2014-10-28 Simplehuman, Llc Trash cans with variable gearing assemblies
US9051093B2 (en) 2013-03-01 2015-06-09 Simplehuman, Llc Receptacle with motion damper near lid
JP5586742B1 (en) * 2013-06-28 2014-09-10 株式会社World Medish Highly flexible stent
JP5550028B1 (en) * 2014-01-27 2014-07-16 株式会社World Medish Highly flexible stent
JP5695259B1 (en) * 2014-02-19 2015-04-01 株式会社World Medish Highly flexible stent
USD730008S1 (en) 2014-03-12 2015-05-19 Simplehuman, Llc Trash can
USD725861S1 (en) 2014-03-13 2015-03-31 Simplehuman, Llc Trash can
US9856080B2 (en) 2014-03-14 2018-01-02 Simplehuman, Llc Containers with multiple sensors
US9751692B2 (en) 2014-03-14 2017-09-05 Simplehuman, Llc Dual sensing receptacles
USD759934S1 (en) 2015-03-05 2016-06-21 Simplehuman, Llc Trash can trim component
USD771344S1 (en) 2015-03-05 2016-11-08 Simplehuman, Llc Trash can
USD804133S1 (en) 2015-12-09 2017-11-28 Simplehuman, Llc Trash can
USD793642S1 (en) 2016-03-04 2017-08-01 Simplehuman, Llc Trash can
USD798016S1 (en) 2016-03-04 2017-09-19 Simplehuman, Llc Trash can
USD835376S1 (en) 2016-11-14 2018-12-04 Simplehuman, Llc Trash can

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4856516A (en) 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
EP0335341A1 (en) 1988-03-28 1989-10-04 EXPANDABLE GRAFTS PARTNERSHIP a Texas General Partnership Expandable intraluminal graft and apparatus for implanting an expandable intraluminal graft
EP0421729A2 (en) 1989-10-02 1991-04-10 Medtronic, Inc. Articulated stent
EP0541443A1 (en) * 1991-11-08 1993-05-12 Meadox Medicals, Inc. Endoprosthesis for transluminal implantation
EP0606165A1 (en) * 1993-01-06 1994-07-13 Ethicon Inc. Stent
EP0669114A1 (en) 1994-02-25 1995-08-30 Robert E. Fischell Stent having a multiplicity of closed circular structures
EP0759730B1 (en) 1994-05-19 1999-02-10 Scimed Life Systems, Inc. Improved tissue supporting devices

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4830003A (en) 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0335341A1 (en) 1988-03-28 1989-10-04 EXPANDABLE GRAFTS PARTNERSHIP a Texas General Partnership Expandable intraluminal graft and apparatus for implanting an expandable intraluminal graft
US4856516A (en) 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
EP0421729A2 (en) 1989-10-02 1991-04-10 Medtronic, Inc. Articulated stent
EP0541443A1 (en) * 1991-11-08 1993-05-12 Meadox Medicals, Inc. Endoprosthesis for transluminal implantation
EP0606165A1 (en) * 1993-01-06 1994-07-13 Ethicon Inc. Stent
EP0669114A1 (en) 1994-02-25 1995-08-30 Robert E. Fischell Stent having a multiplicity of closed circular structures
EP0759730B1 (en) 1994-05-19 1999-02-10 Scimed Life Systems, Inc. Improved tissue supporting devices

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9633671A1

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7279004B2 (en) 1998-03-30 2007-10-09 Innovational Holdings, Llc. Expandable medical device with curved hinge

Also Published As

Publication number Publication date
LV12035B (en) 1999-03-20
CZ292021B6 (en) 2003-07-16
SI0828461T1 (en) 2003-06-30
DE69529692D1 (en) 2003-03-27
BR9510585A (en) 1999-01-05
CA2219488A1 (en) 1996-10-31
AU711431B2 (en) 1999-10-14
FI974063D0 (en)
EP0828461B1 (en) 2003-02-19
WO1996033671A1 (en) 1996-10-31
NZ285241A (en) 1999-03-29
NO974938L (en) 1997-12-19
AU2427995A (en) 1996-11-18
EP0828461B2 (en) 2006-07-05
FI974063A (en) 1997-12-19
DE69529692T3 (en) 2007-02-08
FI974063A0 (en) 1997-10-27
CZ340097A3 (en) 1998-06-17
EP1110515A3 (en) 2001-10-04
HK1038175A1 (en) 2006-09-22
CA2219488C (en) 2003-06-10
RU2154443C2 (en) 2000-08-20
DE19581506T0 (en)
EP1110515A2 (en) 2001-06-27
EP1110515B1 (en) 2006-03-22
JPH11501551A (en) 1999-02-09
ES2190453T3 (en) 2003-08-01
NO974938D0 (en) 1997-10-24
PT828461E (en) 2003-07-31
SK145797A3 (en) 1998-10-07
EP0828461A4 (en) 1999-09-15
DE19581506C2 (en) 2003-06-18
NO310333B1 (en) 2001-06-25
DE19581506T1 (en) 1997-08-21
EE03800B1 (en) 2002-08-15
LV12035A (en) 1998-05-20
AT232703T (en) 2003-03-15
PL322980A1 (en) 1998-03-02
AT320772T (en) 2006-04-15
PL179854B1 (en) 2000-11-30
EE9700296A (en) 1998-04-15
RO115496B1 (en) 2000-03-30
DE69529692T2 (en) 2003-12-18
DK0828461T3 (en) 2003-05-05

Similar Documents

Publication Publication Date Title
EP1181902B1 (en) A flexible expandable stent
EP0951254B1 (en) Low profile self-expanding vascular stent
EP0824902B1 (en) Expandable stent
EP1295575B1 (en) Longitudinally flexible stent
CN1131017C (en) Expandable endovascular stent fixing film
ES2257765T3 (en) Stent flat wire.
US8007527B2 (en) Stent with dual support structure
CA2495000C (en) Stent with improved flexibility
EP0357003B1 (en) Radially expandable endoprothesis
US6183506B1 (en) Expandable stent and method for delivery of same
EP1427353B1 (en) Expandable stent
CA2186029C (en) Improved longitudinally flexible expandable stent
JP3479250B2 (en) Expandable intraluminal endoprosthesis
US6485508B1 (en) Low profile stent
EP0887051B1 (en) Stent with reinforcing struts and bimodal deployment
US6676697B1 (en) Stent with variable features to optimize support and method of making such stent
US6887264B2 (en) Expandable stent and method for delivery of same
US8449597B2 (en) Longitudinally flexible expandable stent
EP1477136B1 (en) Longitudinally flexible expandable stent
US8317851B2 (en) Longitudinally flexible stent
EP2192878B1 (en) Flexible stent with torque-absorbing connectors
US20020165604A1 (en) Expandable medical device with ductile hinges
US5843168A (en) Double wave stent with strut
JP4772807B2 (en) The stent device
US20020019660A1 (en) Methods and apparatus for a curved stent

Legal Events

Date Code Title Description
17P Request for examination filed

Effective date: 19971126

AK Designated contracting states:

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent to

Free format text: LT PAYMENT 971126;SI PAYMENT 971126

AK Designated contracting states:

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Despatch of supplementary search report

Effective date: 19990802

17Q First examination report

Effective date: 20001117

RTI1 Title (correction)

Free format text: ARTICULATED STENT WITH LINKS HAVING KINKS

RTI1 Title (correction)

Free format text: ARTICULATED STENT WITH LINKS HAVING KINKS

RTI1 Title (correction)

Free format text: ARTICULATED STENT WITH LINKS HAVING KINKS

AX Request for extension of the european patent to

Countries concerned: LTSI

AK Designated contracting states:

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REF Corresponds to:

Ref document number: 69529692

Country of ref document: DE

Date of ref document: 20030327

Kind code of ref document: P

PGFP Postgrant: annual fees paid to national office

Ref country code: MC

Payment date: 20030430

Year of fee payment: 09

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

REG Reference to a national code

Ref country code: GR

Ref legal event code: EP

Ref document number: 20030401495

Country of ref document: GR

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: HANS RUDOLF GACHNANG PATENTANWALT

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2190453

Kind code of ref document: T3

ET Fr: translation filed
26 Opposition filed

Opponent name: TERUMO KABUSHIKI KAISHA

Effective date: 20031118

Opponent name: SCIMED LIFE SYSTEMS, INC.

Effective date: 20031119

NLR1 Nl: opposition has been filed with the epo

Opponent name: TERUMO KABUSHIKI KAISHA

Opponent name: SCIMED LIFE SYSTEMS, INC.

PGFP Postgrant: annual fees paid to national office

Ref country code: PT

Payment date: 20040426

Year of fee payment: 10

PGFP Postgrant: annual fees paid to national office

Ref country code: AT

Payment date: 20040428

Year of fee payment: 10

Ref country code: CH

Payment date: 20040428

Year of fee payment: 10

PGFP Postgrant: annual fees paid to national office

Ref country code: DK

Payment date: 20040429

Year of fee payment: 10

Ref country code: GR

Payment date: 20040429

Year of fee payment: 10

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040430

PGFP Postgrant: annual fees paid to national office

Ref country code: LU

Payment date: 20040512

Year of fee payment: 10

PGFP Postgrant: annual fees paid to national office

Ref country code: ES

Payment date: 20040519

Year of fee payment: 10

PGFP Postgrant: annual fees paid to national office

Ref country code: BE

Payment date: 20040617

Year of fee payment: 10

PGFP Postgrant: annual fees paid to national office

Ref country code: NL

Payment date: 20041025

Year of fee payment: 12

LTLA Lt: lapse of european patent or patent extension

Effective date: 20040426

REG Reference to a national code

Ref country code: SI

Ref legal event code: IF

PGFP Postgrant: annual fees paid to national office

Ref country code: SE

Payment date: 20050420

Year of fee payment: 11

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050426

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050426

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050427

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050430

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050430

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050430

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050502

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: PT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20051026

BERE Be: lapsed

Owner name: *MEDINOL LTD

Effective date: 20050430

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20051103

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

NLR1 Nl: opposition has been filed with the epo

Opponent name: TERUMO KABUSHIKI KAISHA

PGFP Postgrant: annual fees paid to national office

Ref country code: FR

Payment date: 20060417

Year of fee payment: 12

PGFP Postgrant: annual fees paid to national office

Ref country code: GB

Payment date: 20060424

Year of fee payment: 12

PGFP Postgrant: annual fees paid to national office

Ref country code: IE

Payment date: 20060425

Year of fee payment: 12

REG Reference to a national code

Ref country code: SI

Ref legal event code: KO00

Effective date: 20060202

PGFP Postgrant: annual fees paid to national office

Ref country code: IT

Payment date: 20060430

Year of fee payment: 12

PGFP Postgrant: annual fees paid to national office

Ref country code: DE

Payment date: 20060531

Year of fee payment: 12

27A Maintained as amended

Effective date: 20060705

AK Designated contracting states:

Kind code of ref document: B2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent to

Countries concerned: LTSI

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20050427

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20050427

NLR2 Nl: decision of opposition

Effective date: 20060705

NLR3 Nl: receipt of modified translations in the netherlands language after an opposition procedure
ET3 Fr: translation filed ** decision concerning opposition
GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20070426

BERE Be: lapsed

Owner name: *MEDINOL LTD

Effective date: 20050430

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20071101

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071101

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071101

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070426

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070426

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070430

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060427

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070426